Change of Membrane Potential is Not Required for the Tumour Necrosis Factor-α Mediated Cytotoxicity

References

• Beutler B., Greenwald D., Hulmes J. D. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985; 316: 552
   PubMed Web of Science ®Google Scholar
• Sugarman B. J., Aggarwal B. B., Hass P. E., Figari I. S., Palladino M. A., Jr., Shepard H. H. Recombinant human necrosis factor-a: effects on proliferation of normal and transformed cells in vitro. Science 1985; 230: 943
   PubMed Web of Science ®Google Scholar
• Meager A., Leung H., Woolley J. Assays for tumour necrosis factor and related cytokines. J. Immunol., Method. 1989; 116: 1
   PubMed Web of Science ®Google Scholar
• Fung K. P., Leung S. W., Ha D. KJC., Ng S. W., Choy Y. M., Lee C. Y. Effects of tumour necrosis factor on growth of Ehrlich ascites tumour cells in vitro and in vivo. Cane, lett. 1985; 27: 269
   PubMed Web of Science ®Google Scholar
• Palombella V. J., Mendelsohu J., Vilcek J. Mitogenic action of tumour necrosis factor in human fibroblasts: Interaction with epidermal growth factor and platelet-derived growth factor. J. Cell. Physiol. 1988; 135: 23
   PubMed Web of Science ®Google Scholar
• Fiers W. Tumour necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 1991; 285: 199
   PubMed Web of Science ®Google Scholar
• Kull F. C., Jacobs S., Cuatrecasas P. Cellular receptor for 1251-labelled tumour necrosis factor: Specific binding, affinity labelling, and relationship to sensitivity. Proc. Natl., Acad., Sci., USA 1985; 82: 5756
   PubMed Web of Science ®Google Scholar
• Tsujimoto M., Kip Y JC., Vileck J. Tumour necrosis factor: specific binding and internalization in sensitive and resistant cells. Proc. Natl., Acad., Sci., USA 1985; 82: 7626
   PubMed Web of Science ®Google Scholar
• Kronke M., Schutze S., Scheurich P., Meichle A., Hensel G., Thoma B., Kruppa G., Pfizenmaier K. Tumour necrosis factor signal transduction. Cell signalling 1990; 2: 1
   PubMed Web of Science ®Google Scholar
• Baglioni C. Mechanisms of cytotoxicity, cytolysis, and growth stimulation by TNF. Tumour necrosis factor: The molecules and their emerging role in medicine, B. Beutler. Raven press. 1992; 425
   Google Scholar
• Baud L., Perez J., Friedlander G., Ardaillou R. Tumour necrosis factor stimulates prostaglandin production and cAMP levels in rat cultured mesangial cells. FEBS lett. 1988; 239: 50
   PubMed Web of Science ®Google Scholar
• Zhang Y., Lin J. X., Yip Y. K., Vileck J. Enhancement of cAMP levels and of protein kinase activity by tumour necrosis factor and interleukin 1 in human fibroblasts: Role in the induction of interleukin 6. Proc. Natl., Acad., Sci., USA 1988; 85: 6802
   PubMed Web of Science ®Google Scholar
• Chun M., Hoffmann M. K. Intracellular cAMP regulates the cytotoxicity of recombinant tumour necrosis factor for L cells in vitro. Lymphokine Res. 1987; 6: 161
   PubMedGoogle Scholar
• Scheurich P., Kobrich G., Pfizenmaier K. Antagonistic control of tumour necrosis factor receptors by protein kinases A and C. Enhancement of TNF receptor synthesis by PKA and transmodulation of receptors by PKC. J. Exp. Med. 1989; 170: 947
   PubMed Web of Science ®Google Scholar
• Bouchelouche P. N., Bendtzen K., Bak S., Nielsen O. H. Recombinant human tumour necrosis factor increases cytosolic free calcium in murine fibroblasts and stimulates inositol phosphate formation in L-M and arachidonic acid release in 3T3 cells. Cell signalling 1990; 2: 79
   Web of Science ®Google Scholar
• Hasegawa Y., Bonavida B. Calcium-independent pathway of tumour necrosis factor mediated lysis of target cells. J. Immunol. 1989; 142: 2670
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B., Cragoe E. J., Jr., Pouyssegur J., Beyaert R., Van Roy F., Fiers W. Cytotoxic activity of tumour necrosis factor is inhibited by amiloride derivatives without involvement of the Na+/H+ antiporter. FEBS lett. 1990; 261: 319
   PubMed Web of Science ®Google Scholar
• Donato N. J., Ince C, Rosenblum M. G., Gallick G. E. Early events in the antiproliferative action of tumour necrosis factor are similar to the early events in epidermal growth factor growth stimulation. J. Cell. Biochem. 1989; 41: 139
   PubMed Web of Science ®Google Scholar
• Clark M. A., Chen M. J., Crooke S. T., Bomalaski J. S. Tumour necrosis factor (Cachetin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells. Biochem. J. 1988; 250: 125
   PubMed Web of Science ®Google Scholar
• Dressier K. A., Mathias S., Kolesnick R. N. Tumour necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science 1992; 255: 1715
   PubMed Web of Science ®Google Scholar
• Kagan B. L., Baldwin R. L., Munoz D., Wisnieski B. J. Formation of ion-permeable channels by tumour necrosis factor-α. Science 1992; 255: 1427
   PubMed Web of Science ®Google Scholar
• Kirstein M., Baglioni C. Tumour necrosis factor induces synthesis of two proteins in human fibrobalsts. J. Biol. Chem. 1986; 261: 9565
   PubMed Web of Science ®Google Scholar
• Kong S. K., Suen Y. K., Choy Y. M., Fung K. P., Lee C. Y. Membrane depolarization was required to induce DNA synthesis in murine macrophage cell line PU5–1.8. Immunopharm. Immunotoxi. 1991; 13: 329
   PubMed Web of Science ®Google Scholar
• Grinstein S., Dixon S J. Ion transport, membrane potential and cytoplasmic pH in lymphocytes: changes during activation. Physiol. Rev. 1989; 69: 417
   PubMed Web of Science ®Google Scholar
• Sawada M., Hara N., Maeno T. Extracellular tumour necrosis factor induces a decreased K+ conductance in an identified neuron of Aplysia kurodai. Neurosci Lett. 1990; 115: 219
   PubMed Web of Science ®Google Scholar
• Tracey K. J., Lowery S. F., Beutler B., Cerami A., Albert J. D., Shires G. T. Cachetin/Tumour necrosis factor mediates changes of skeletal muscle plasma membrane potential. J. Exp., Med. 1986; 164: 1368
   PubMed Web of Science ®Google Scholar
• Yuo A., Kitagawa S., Suzuki I., Urabe A., Okabe T., Saito M., Takaku F. Tumour necrosis factor as an activator of human granulocytes. Potentiation of the metabolisms triggers by the calcium-mobilizing agets. J. Immunol. 1989; 142: 1678
   PubMed Web of Science ®Google Scholar